Bharat Immunologicals & Biologicals Corporation

Stock Price vs Company Growth
1d
4.4%
1w
10.2%
1m
0.1%
3m
22.1%
6m
16.4%
1y
31.5%
5y
26.9%
10y
5.9%
all
4.0%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec16Dec18Sep20Jun22Dec23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

22.4 4.4%
19
29.6
Company Overview

Sales
26.5 Cr
Growth: -28.9%
Profit after Tax
-17.3 Cr
Growth: -0.5%
Micro Cap
96.7 Cr
P/S: 3.7x
Industry P/S: 2.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 26.5
Growth -28.9%
EBITDA N/A
P/S 3.7x
Dividend 0.0%
P/E -5.6x
Book Value ₹ 10
PEG Ratio 0.2x
ROE -40.0%
P/B N/A
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Sep22Sep23
Promoters
Created with Highcharts 8.2.2Sep22Sep23
Others
Created with Highcharts 8.2.2Sep22Sep23
Increase    Decrease    No change
Company Profile Detailed

:The Company's principal activity is to manufacture and supply of oral polio vaccine. It supplies oral polio vaccine to Government of India. Its plant is located in Bulandshahr, Uttar Pradesh.The live oral polio vaccine (OPV) is a trivalent vaccine containing suspensions of type 1,2 and 3 attenuated poliomyelitis viruses (Sabin strains) prepared in primary moneky kidney cell culture. Each dose contains Poliovirus type 1 = 106.0Poliovirus type 2 = 105.0Poliovirus type 3 = 105.
Belongs to (1 Indices)